It has been hypothesized that in MCPH1 patients the G2/M checkpoint in response to DNA damage is still competent, but causes a longer delay in cell cycle re-entry, which might explain the microcephaly phenotype in the absence of a clear cancer predisposition. The gene discussed is MCPH1; the disease is microcephaly.